Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2026
- Sponsor
- Sen. Moody, Ashley [R-FL]
- Committees
- Health, Education, Labor, and Pensions Committee (primary)
- Last action
- Feb 25, 2026
Bottom line
This bill aims to deregulate a specific category of traditional and premium cigars from FDA oversight, citing the need to protect associated small businesses and jobs.
What it actually does
This bill amends the Federal Food, Drug, and Cosmetic Act to explicitly exempt "traditional large and premium cigars" from most of the Food and Drug Administration's (FDA) regulatory authority over tobacco products. It provides a highly specific definition for these cigars, based on their all-tobacco composition, lack of filters, minimum weight, and specific manufacturing methods, while explicitly excluding cigarettes and little cigars.
Proponents argue
Proponents argue that traditional large and premium cigars are distinct from other tobacco products, with different usage patterns and health profiles, and that current FDA regulations impose undue burdens that threaten small businesses and jobs in the traditional cigar industry. They contend that these artisanal products do not warrant the same stringent oversight as mass-produced tobacco products.
Opponents contend
Opponents would likely argue that all tobacco products, including premium cigars, pose health risks and should remain under comprehensive FDA jurisdiction to protect public health. They might contend that creating exemptions could open loopholes, complicate regulatory enforcement, and potentially lead to increased tobacco use or exposure to harmful substances, especially if the definition is exploited.
The bill text is very short and straightforward, making it highly accessible for a quick read and understanding of its core purpose.
Section 2(a)
Exemption of Traditional Large and Premium Cigars from FDA Authority
This provision amends the Federal Food, Drug, and Cosmetic Act to explicitly remove "traditional large and premium cigars" from the Food and Drug Administration's regulatory authority, with the exception of section 907(d)(3) (which relates to tobacco product standards for certain components). It also clarifies that the Secretary of Health and Human Services cannot issue regulations on these specific cigar types. The bill provides a precise definition for what constitutes a "traditional large and premium cigar," focusing on its all-tobacco composition, lack of filters, weight, and specific manufacturing methods (hand-rolled or specific machine-assisted processes).
Supporters argue
Supporters argue that these cigars are distinct products, often consumed differently and by a different demographic than other tobacco products, and do not warrant the same level of FDA scrutiny. They believe that deregulation will preserve a traditional industry, protect small businesses from burdensome compliance costs, and prevent job losses.
Critics contend
Critics contend that exempting any tobacco product from FDA oversight undermines public health efforts and could lead to increased consumption or exposure to harmful substances. They argue that all tobacco products carry health risks and should be subject to comprehensive regulation to protect consumers, especially youth.
Tradeoffs
The provision balances the economic interests of the traditional cigar industry and small businesses against public health concerns regarding tobacco product regulation. It highlights the tension between industry-specific economic protection and broad public health policy.
Section 2(b)
Conforming Amendments for User Fees
This section makes technical adjustments to existing law (Section 919(b) of the Federal Food, Drug, and Cosmetic Act) to ensure that traditional large and premium cigars, as defined in the bill, are explicitly excluded from certain user fees that would otherwise apply to tobacco products. This reinforces the intent of the main provision to remove these cigars from FDA's financial and regulatory purview.
Defines "traditional large and premium cigar" with specific criteria: 100% leaf tobacco wrapper, 100% tobacco filler, no filter/tip/non-tobacco mouthpiece, minimum weight of 6 pounds per 1,000 count, and specific manufacturing methods (hand-rolled with 100% leaf tobacco binder, or machine-assisted with human hands for wrapper/binder with 100% leaf tobacco binder, or machine-assisted with human hands for wrapper with homogenized tobacco leaf binder made in the US). It also explicitly excludes cigarettes and little cigars.
Section 2(a)(3)(C)
Why it matters:This level of detail is standard legislative practice for defining the scope of an exemption or new category, ensuring legal precision and preventing unintended applications.
Case for: Supporters argue that a precise definition is crucial to ensure that only genuinely traditional and premium cigars, which they contend have different market dynamics and consumption patterns, are exempted, preventing other tobacco products from exploiting the loophole.
Case against: Critics might argue that the complexity of the definition could still lead to ambiguity or create incentives for manufacturers to alter products to fit the exemption, potentially undermining public health goals.
Estimated impact: This definition directly determines which segment of the cigar market will be deregulated, impacting potentially billions in sales and thousands of jobs in the specific traditional and premium cigar sector.